MUSC study provides new insight that may lead to personalized repetitive transcranial magnetic stimulation, or rTMS, for smokers who want to quit.

As the U.S. marks Pain Awareness Month, MUSC Health has several new options for treating pain.

MUSC is betting big on its own innovative culture, announcing launch of first venture fund: 1824 Health Ventures Fund I, LP.

Researchers find a nuanced approach to treating intracranial internal carotid artery aneurysms can be done safely and may get better outcomes.

MUSC researchers have engineered a new type of genetically modified immune cell that could help organ transplant patients who are prone to rejection.

Surgical team becomes first to test for, repair nerve damage in people with rib injuries/abdominal wall trauma before it’s too late.

An MUSC study lays the scientific groundwork for a new approach to preventing compromised kidney function and kidney failure in patients with lupus.

MUSC redevelops online Bachelor of Science in Healthcare Studies (HCS) program, making it fully artificial intelligence (AI)-integrated.

A program aimed at improving patients’ experiences in 2 Emergency Departments in Charleston has been such a success that it’s expanding to other hospitals.

With $26.5 million in new funding, SCTR will clear the way for the translation of research breakthroughs into clinics and communities.